Breaking News
Stay up to date with the latest longevity trends.
Breaking News
Stay up to date with the latest longevity trends.
Breaking News — NMN
New Clinical Trial Finds Uthever NMN to Increase NAD+ By 38%, Reduce Insulin Resistance, and Improve Quality of Life
ProHealth Uthever NMN at 300 mg per day for 60 days increased NAD+ levels by 49%, reduced insulin resistance, and improved Quality of Life scores in a clinical trial of 66 healthy middle-aged adults.
Top doc tells NBC-TV viewers about NMN for healthy aging
Jennifer Pearlman, MD, CCFP, NCMP, FAARM, ABAARM, is an internationally recognized healthy aging expert. She is such a big believer in ProHealth Longevity’s Uthever NMN that she joined the ProHealth Longevity Scientific Advisory Board earlier this year.
ProHealth, Inc. Becomes Authorized Distributor of Uthever® NMN by Effepharm
Leading longevity company teams up with leading global biotechnology manufacturer to offer world’s best NMN
Recent articles